Shensu IV prevents glomerular podocyte injury in nephrotic rats via promoting lncRNA H19/DIRAS3-mediated autophagy

Shensu IV is a Chinese prescription well-known for its function in treating chronic kidney diseases. However, the potential mechanisms underlying how Shensu IV exerts its effects remain unclear. In the present study, we investigated the effects of Shensu IV on glomerular podocyte injury in nephrotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong, Huang, Yaqian, Zhou, Yehua, Cheng, Jie, Wan, Chanjun, Wang, Maohong, Pi, Chiheng, Wu, Guoqing, Song, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Cell Homeostasis & Autophagy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112846/
https://www.ncbi.nlm.nih.gov/pubmed/33881140
http://dx.doi.org/10.1042/BSR20203362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112846/
https://www.ncbi.nlm.nih.gov/pubmed/33881140
http://dx.doi.org/10.1042/BSR20203362

Ejemplares similares